Release Date: 17/09/12 09:37 Summary: Ceasing to be a substantial holder Price Sensitive: No Download Document 431.72KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%